Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment (FAST) | Zendy

Lucas V.A. Boersma | Zendy; Manuel Castellá | Zendy; Wim-Jan van Boven | Zendy; Antonio Berruezo | Zendy; Alaaddin Yılmaz | Zendy; Mercedes Muro de Nadal | Zendy; Elena Sandoval | Zendy; Naiara Calvo | Zendy; Josép Brugada | Zendy; Johannes C. Kelder | Zendy; M. C. E. F. Wijffels | Zendy; Lluı́s Mont | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment (FAST)

Author(s) -

Lucas V.A. Boersma,

Manuel Castellá,

Wim-Jan van Boven,

Antonio Berruezo,

Alaaddin Yılmaz,

Mercedes Muro de Nadal,

Elena Sandoval,

Naiara Calvo,

Josép Brugada,

Johannes C. Kelder,

M. C. E. F. Wijffels,

Lluı́s Mont

Publication year - 2011

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.111.074047

Subject(s) - medicine , atrial fibrillation , pulmonary vein , ablation , cardiology , catheter ablation , refractory (planetary science) , ablation of atrial fibrillation , clinical endpoint , randomized controlled trial , pneumothorax , anesthesia , left pulmonary vein , surgery , physics , astrobiology

Catheter ablation (CA) and minimally invasive surgical ablation (SA) have become accepted therapy for antiarrhythmic drug-refractory atrial fibrillation. This study describes the first randomized clinical trial comparing their efficacy and safety during a 12-month follow-up.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research